e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Asthma: clinical aspects and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Fluticasone increases in vitro efferocytosis by human alveolar macrophages
J. C. Todt, T. Ames, J. Sonstein, T. Polak, C. M. Freeman, M. Han, F. J. Martinez, J. L. Curtis (Ann Arbor, United States Of America)
Source:
Annual Congress 2010 - Asthma: clinical aspects and treatment
Session:
Asthma: clinical aspects and treatment
Session type:
E-Communication Session
Number:
3958
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. C. Todt, T. Ames, J. Sonstein, T. Polak, C. M. Freeman, M. Han, F. J. Martinez, J. L. Curtis (Ann Arbor, United States Of America). Fluticasone increases in vitro efferocytosis by human alveolar macrophages. Eur Respir J 2010; 36: Suppl. 54, 3958
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Azithromycin increases phagocytosis of apoptotic airway epithelial cells by alveolar macrophages
in vitro
Source: Annual Congress 2005 - Cellular and molecular approaches to lung injury research
Year: 2005
Increased SDF-1alpha production from alveolar macrophages in sarcoidosis in vitro
Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity
Year: 2008
Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages
Source: Eur Respir J 2006; 28: 486-495
Year: 2006
Cigarette smoke-induced IL-8 production by human monocyte-derived macrophages: synergistic inhibition by fluticasone and salmeterol
Source: Eur Respir J 2005; 26: Suppl. 49, 14s
Year: 2005
Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages (AM) in COPD
Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Year: 2011
Tiotropium bromide reduces PMN chemotaxis induced by alveolar macrophages of COPD patients
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008
Prostaglandin-E
2
mediated inhibition of TNFα release from human alveolar macrophages
Source: Eur Respir J 2005; 26: Suppl. 49, 223s
Year: 2005
Cytokine-induced production of eotaxin-3 by human lung epithelial cells is inhibited by levocetirizine
Source: Eur Respir J 2005; 26: Suppl. 49, 98s
Year: 2005
Glucocorticoid sensitivity of LPS stimulated COPD alveolar macrophages
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Antiinflammatory effects of formoterol in macrophages as a model for alveolar macrophages in COPD
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II
Year: 2008
Tiotropium inhibits acetylcholine-induced generation of proinflammatory microparticles by human pulmonary epithelial cells
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018
Increased in vitro production of IP-10/CXCL10 and MIG/CXCL9 by alveolar macrophages in sarcoidosis and EAA but not in IPF
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008
Glucocorticoids induce a shift in chemokine profile in LPS-stimulated human alveolar macrophages
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018
IL-17-induced release of GRO-alpha in human bronchial epithelial cells
in vitro
Source: Eur Respir J 2001; 18: Suppl. 33, 520s
Year: 2001
Synergistic anti-inflammatory effects of salmeterol and fluticasone on the release of IL-8 and MCP-1 by human bronchial epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 39s
Year: 2003
N-acetylcysteine reduces tumor necrosis factor-α release by alveolar macrophages of interstitial lung disease
in vitro
Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Year: 2007
Budesonide and formoterol inhibit bronchial epithelial cell-mediated eosinophil superoxide production
Source: Eur Respir J 2005; 26: Suppl. 49, 123s
Year: 2005
Tiotropium and fluticasone inhibit rhinovirus-induced mucin production via multiple mechanisms in differentiated airway epithelial cells
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020
Histamine-stimulated monocytes release microparticles that upregulate IL-8 synthesis by human alveolar epithelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 228s
Year: 2006
Inhibition of IL-8 and RANTES release from cultured human airway smooth muscle cells by fluticasone and budesonide
Source: Eur Respir J 2002; 20: Suppl. 38, 384s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept